INNOVIVA, INC. (INVA) ROI
- 2017-06-30: ROI 22.93%.
- 2016-12-31: ROI 28.60%.
Complete source-backed roi history.
- Available history
- 2015-12-31 to 2017-06-30
- Data captured
Historical ROI
| Date | ROI |
|---|---|
| 2017-06-30 | 22.93% |
| 2016-12-31 | 28.60% |
Annual ROI
| Date | ROI |
|---|---|
| 2016-12-31 | 16.40% |
| 2015-12-31 | -4.80% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| OMEROS CORP (OMER) | United States | $1.456B | 5.50 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |